SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-135186
Filing Date
2016-07-29
Accepted
2016-07-29 07:43:59
Documents
10
Period of Report
2016-07-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-15624_18k.htm 8-K 25231
2 EX-99.1 a16-15624_1ex99d1.htm EX-99.1 665908
3 GRAPHIC g156241mm05i001.gif GRAPHIC 2573
4 GRAPHIC g156241mm15i001.gif GRAPHIC 2573
5 GRAPHIC g156241mm11i001.gif GRAPHIC 2578
6 GRAPHIC g156241mm07i001.gif GRAPHIC 2578
7 GRAPHIC g156241mm03i001.gif GRAPHIC 2068
8 GRAPHIC g156241mm09i001.gif GRAPHIC 2573
9 GRAPHIC g156241mm01i001.gif GRAPHIC 2578
10 GRAPHIC g156241mm13i001.jpg GRAPHIC 1871
  Complete submission text file 0001104659-16-135186.txt   720160
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35565 | Film No.: 161791976
SIC: 2834 Pharmaceutical Preparations